Stories about breast cancer that can inspire and inform

Blog  |  Newsroom

Helen’s Story:  Financial Help From Komen Allowed Me To Be Here For My Grandchildren

Helen was helping care for her grandchildren when she was diagnosed with breast cancer. While her treatment costs were covered under Medicaid, Helen had other bills she needed help with. “I worried about my electricity being turned off,” she said. That’s when she turned to Komen’s Financial Assistance Program for help.

LaShae’s Story: From Cancer Prevention Researcher to Breast Cancer Survivor

LaShae was working on her Ph.D. in public health, focused on cancer prevention research, when she was diagnosed with breast cancer. “My journey has taught me the value of advocacy and support for young adults with cancer,” said LaShae. “I am committed to helping others navigate their journeys through similar challenges.”

Colleen’s Story: Financial Help Took A Huge Weight Off Me While Recovering From Breast Cancer Surgery

During treatment for breast cancer, Colleen had to take time off from work. While Medicaid covered her treatment costs, Colleen had other bills to pay. She applied for help through Komen’s Financial Assistance Program. “Komen’s help took a huge weight off of me while recovering from surgery,” she said. “I was able to focus on taking care of myself.”

Shining a Spotlight on the Unmet Needs of Patients with Advanced ER-Positive / HER2-Negative Breast Cancer 

For breast cancer researchers, one of the biggest goals of a clinical trial is to address the unmet needs of people living with advanced breast cancer. Advanced breast cancer is difficult to cure or control with treatment. The cancer may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body, i.e. bones, lungs, brain, or liver.  Patients with advanced breast cancer need more treatment options.  

Breast Cancer Breakthroughs Episode 10: Highlights from the ASCO 2024 Annual Meeting 

In this episode of Breast Cancer Breakthroughs, we speak with Komen grantees Dr. Tarah Ballinger, medical oncologist at Indiana University School of Medicine, and Dr. Pedram Razavi, medical oncologist at Memorial Sloan Kettering Cancer Center, about the biggest highlights from the 2024 ASCO Annual Meeting and what they could mean for patients.